Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
glykopyrrolat 500 mikrogram/ml + neostigminmetylsulfat 2,5 mg/ml, injektionsvätska, lösning, ampull |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
glykopyrrolat 500 mikrogram/ml + neostigminmetylsulfat 2,5 mg/ml, injektionsvätska, lösning, ampull |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
2 |
heparinnatrium 5 000 enheter/5 ml, injektionsvätska, lösning, flaska |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
heparinnatrium 5 000 enheter/5 ml, injektionsvätska, lösning, flaska |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
vattenfri glukos 20 g + kaliumklorid 750 mg + natriumklorid 900 mg per 500 ml, infusionsvätska, lösning, påse |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
vattenfri glukos 20 g + kaliumklorid 750 mg + natriumklorid 900 mg per 500 ml, infusionsvätska, lösning, påse |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
vattenfri glukos 20 g + kaliumklorid 750 mg + natriumklorid 900 mg per 500 ml, infusionsvätska, lösning, påse |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
2 |
vattenfri glukos 20 g + kaliumklorid 750 mg + natriumklorid 900 mg per 500 ml, infusionsvätska, lösning, påse |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
3 |
vattenfri glukos 20 g + kaliumklorid 750 mg + natriumklorid 900 mg per 500 ml, infusionsvätska, lösning, påse |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
3 |
vattenfri glukos 20 g + kaliumklorid 750 mg + natriumklorid 900 mg per 500 ml, infusionsvätska, lösning, påse |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
2 |
pralidoximmesilat 1 g/5 ml, injektionsvätska, lösning, ampull |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
pralidoximmesilat 1 g/5 ml, injektionsvätska, lösning, ampull |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
metadonhydroklorid 20 mg/2 ml, injektionsvätska, lösning, ampull |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
metadonhydroklorid 20 mg/2 ml, injektionsvätska, lösning, ampull |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
peginterferon alfa-2a 135 mikrogram/0,5 ml, injektionsvätska, lösning, spruta |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
peginterferon alfa-2a 135 mikrogram/0,5 ml, injektionsvätska, lösning, spruta |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
prednisolonacetat 25 mg/ml, injektionsvätska, suspension, ampull |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
prednisolonacetat 25 mg/ml, injektionsvätska, suspension, ampull |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
netilmicin (som netilmicinsulfat) 100 mg/ml, injektionsvätska, lösning, ampull |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
netilmicin (som netilmicinsulfat) 100 mg/ml, injektionsvätska, lösning, ampull |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
heparinnatrium 25 000 enheter/5 ml, injektionsvätska, lösning, ampull |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
heparinnatrium 25 000 enheter/5 ml, injektionsvätska, lösning, ampull |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
labetalolhydroklorid 100 mg/20 ml, injektionsvätska, lösning, ampull |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
labetalolhydroklorid 100 mg/20 ml, injektionsvätska, lösning, ampull |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
levofloxacin (som levofloxacinhemihydrat) 500 mg/100 ml, infusionsvätska, lösning, flaska |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
levofloxacin (som levofloxacinhemihydrat) 500 mg/100 ml, infusionsvätska, lösning, flaska |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
triamcinolonacetonid 40 mg/ml, injektionsvätska, suspension, flaska |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
triamcinolonacetonid 40 mg/ml, injektionsvätska, suspension, flaska |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
netilmicin (som netilmicinsulfat) 200 mg/2 ml, injektionsvätska, lösning, ampull |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
netilmicin (som netilmicinsulfat) 200 mg/2 ml, injektionsvätska, lösning, ampull |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
hepatit B-ytantigen, 20 mikrogram/ml, injektionsvätska, suspension, flaska |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
hepatit B-ytantigen, 20 mikrogram/ml, injektionsvätska, suspension, flaska |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
tinzaparinnatrium 20 000 enheter/2 ml, injektionsvätska, lösning, flaska |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
tinzaparinnatrium 20 000 enheter/2 ml, injektionsvätska, lösning, flaska |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
lidokainhydroklorid 50 mg/10 ml, injektionsvätska, lösning, ampull |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
lidokainhydroklorid 50 mg/10 ml, injektionsvätska, lösning, ampull |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
triamcinolonacetonid 80 mg/2 ml, injektionsvätska, suspension, spruta |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
triamcinolonacetonid 80 mg/2 ml, injektionsvätska, suspension, spruta |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
hepatit B-ytantigen, 10 mikrogram/0,5 ml, injektionsvätska, suspension, flaska |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
hepatit B-ytantigen, 10 mikrogram/0,5 ml, injektionsvätska, suspension, flaska |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
levetiracetam 500 mg/5 ml, injektionsvätska, lösning, flaska |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
levetiracetam 500 mg/5 ml, injektionsvätska, lösning, flaska |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
lidokainhydroklorid 20 mg/2 ml, injektionsvätska, lösning, ampull |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
lidokainhydroklorid 20 mg/2 ml, injektionsvätska, lösning, ampull |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
triamcinolonhexacetonid 100 mg/5 ml, injektionsvätska, suspension, flaska |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
triamcinolonhexacetonid 100 mg/5 ml, injektionsvätska, suspension, flaska |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
netilmicin (som netilmicinsulfat) 50 mg/ml, injektionsvätska, lösning, ampull |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
netilmicin (som netilmicinsulfat) 50 mg/ml, injektionsvätska, lösning, ampull |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
proklorperazinmesilat 12,5 mg/ml, injektionsvätska, lösning, ampull |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
proklorperazinmesilat 12,5 mg/ml, injektionsvätska, lösning, ampull |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
lidokainhydroklorid 200 mg/20 ml, injektionsvätska, lösning, ampull |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
lidokainhydroklorid 200 mg/20 ml, injektionsvätska, lösning, ampull |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
nimodipin 10 mg/50 ml, infusionsvätska, lösning, flaska |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
nimodipin 10 mg/50 ml, infusionsvätska, lösning, flaska |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
hydrokortison (som hydrokortisonnatriumfosfat) 100 mg/ml, injektionsvätska, lösning, ampull |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
hydrokortison (som hydrokortisonnatriumfosfat) 100 mg/ml, injektionsvätska, lösning, ampull |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
progesteron 50 mg/ml, injektionsvätska, lösning, ampull |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
progesteron 50 mg/ml, injektionsvätska, lösning, ampull |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
trimetoprim 100 mg/5 ml, injektionsvätska, lösning, ampull |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
trimetoprim 100 mg/5 ml, injektionsvätska, lösning, ampull |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
nizatidin 100 mg/4 ml, injektionsvätska, lösning, ampull |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
nizatidin 100 mg/4 ml, injektionsvätska, lösning, ampull |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
lidokainhydroklorid 100 mg/10ml, injektionsvätska, lösning, spruta |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
lidokainhydroklorid 100 mg/10ml, injektionsvätska, lösning, spruta |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
trinatriumedetat 1 g/5 ml, injektionsvätska, lösning, ampull |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
trinatriumedetat 1 g/5 ml, injektionsvätska, lösning, ampull |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
noradrenalin (som noradrenalinbitartrat) 20 mg/20 ml, infusionsvätska, lösning, ampull |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
noradrenalin (som noradrenalinbitartrat) 20 mg/20 ml, infusionsvätska, lösning, ampull |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
hydrokortisonacetat 25 mg/ml, injektionsvätska, suspension, ampull |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
hydrokortisonacetat 25 mg/ml, injektionsvätska, suspension, ampull |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
terbutalinsulfat 500 mikrogram/ml, injektionsvätska, lösning, ampull |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
terbutalinsulfat 500 mikrogram/ml, injektionsvätska, lösning, ampull |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
danaparoidnatrium 750 enheter/0,6 ml, injektionsvätska, lösning, ampull |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
danaparoidnatrium 750 enheter/0,6 ml, injektionsvätska, lösning, ampull |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
teriparatid 750 mikrogram/3 ml, injektionsvätska, lösning, spruta |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
teriparatid 750 mikrogram/3 ml, injektionsvätska, lösning, spruta |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
digoxin 100 mikrogram/ml, injektionsvätska, lösning, ampull |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
digoxin 100 mikrogram/ml, injektionsvätska, lösning, ampull |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
tetrakosaktidacetat 250 mikrogram/ml, injektionsvätska, lösning, ampull |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
tetrakosaktidacetat 250 mikrogram/ml, injektionsvätska, lösning, ampull |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
järn (som järnsackaros) 100 mg/5 ml, injektionsvätska, lösning, ampull |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
järn (som järnsackaros) 100 mg/5 ml, injektionsvätska, lösning, ampull |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
adrenalin 300 mikrogram/0,3 ml, injektionsvätska, lösning, spruta |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
adrenalin 300 mikrogram/0,3 ml, injektionsvätska, lösning, spruta |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
ketorolaktrometamin 30 mg/ml, injektionsvätska, lösning, ampull |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
ketorolaktrometamin 30 mg/ml, injektionsvätska, lösning, ampull |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
ergonovinmaleat 500 mikrogram/ml, injektionsvätska, lösning, ampull |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
ergonovinmaleat 500 mikrogram/ml, injektionsvätska, lösning, ampull |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
ropivakainhydroklorid 400 mg/200 ml, infusionsvätska, lösning, påse |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
ropivakainhydroklorid 400 mg/200 ml, infusionsvätska, lösning, påse |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
fluorouracil (som fluorouracilnatrium) 500 mg/10 ml, injektionsvätska, lösning, flaska |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
fluorouracil (som fluorouracilnatrium) 500 mg/10 ml, injektionsvätska, lösning, flaska |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
fluorouracil (som fluorouracilnatrium) 2,5 g/50 ml, infusionsvätska, lösning, flaska |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
fluorouracil (som fluorouracilnatrium) 2,5 g/50 ml, infusionsvätska, lösning, flaska |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
gadodiamid 5 mmol/10 ml, injektionsvätska, lösning, flaska |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
gadodiamid 5 mmol/10 ml, injektionsvätska, lösning, flaska |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
gadodiamid 7,5 mmol/15 ml, injektionsvätska, lösning, flaska |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
gadodiamid 7,5 mmol/15 ml, injektionsvätska, lösning, flaska |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
gadodiamid 10 mmol/20 ml, injektionsvätska, lösning, flaska |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
gadodiamid 10 mmol/20 ml, injektionsvätska, lösning, flaska |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
glykopyrrolat 200 mikrogram/ml, injektionsvätska, lösning, ampull |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |